[PHP347] Adaptive Pathways May Expand The Gap Between Regulators And Payers
2015 Value in Health
Toumi, M. | Rémuzat, C. | Thivolet, M. |
Adaptive pathways (AP) are prospective planned approaches to regulation and coverage of drugs. Through iterative phases of evidence gathering, it aims to reduce uncertainties while balancing timely access for patients and level of available evidence. The concept assumes that all phases from development to clinical routine use through reimbursement are integrated. If AP did develop from regulatory perspective, many payers remain resistant. The aim of this research is to discuss payer’s position on AP.